Related Experiment Video

Updated: May 8, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal syndrome type 4: a review

Anna Clementi, Grazia Maria Virzì, Ching Yan Goh

    Cardiorenal Medicine
    |August 16, 2013
    PubMed

    Insights

    Cardiorenal syndrome type 4 (CRS type 4) involves chronic kidney disease impacting heart function, leading to serious cardiac issues. This review covers its epidemiology, pathophysiology, early detection biomarkers, and management strategies.

    Area of Science:

    • Nephrology
    • Cardiology
    • Internal Medicine

    Background:

    • The heart and kidneys share a complex, bidirectional relationship influencing overall health.
    • Cardiorenal syndrome type 4 (CRS type 4) is defined by chronic kidney disease (CKD) negatively affecting cardiac function.
    • Increasing CKD incidence elevates CRS type 4 as a significant public health concern with high mortality.

    Purpose of the Study:

    • To review the epidemiology and pathophysiology of CRS type 4.
    • To explore the role of biomarkers in the early identification of CRS type 4.
    • To discuss current management strategies for CRS type 4.

    Main Methods:

    • Literature review focusing on epidemiology.
    • Pathophysiological mechanism analysis.
    • Biomarker and clinical management review.

    Main Results:

    • CRS type 4 presents with ventricular hypertrophy and diastolic dysfunction.
    • Early identification of CRS type 4 is crucial for mitigating adverse cardiovascular events.
    • Effective management strategies are essential for improving patient outcomes.

    Conclusions:

    • CRS type 4 represents a growing challenge due to the rising prevalence of CKD.
    • Understanding the intricate cardiorenal link is key to managing CRS type 4.
    • Further research into biomarkers and therapeutic interventions is warranted.

    Keywords:
    BiomarkersCardiorenal syndrome type 4Cardiovascular eventsChronic kidney disease

    More Related Videos

    Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury10:25

    Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

    Published on: August 30, 2011

    Related Concept Videos

    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Rheumatic Heart Disease IV: Nursing Management01:20

    Rheumatic Heart Disease IV: Nursing Management

    AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...